
Trenekop Injection
Marketer
Kopran Ltd
Salt Composition
Tranexamic Acid (500mg)
Overview Trenekop Injection
Hemostatin Injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss associated with procedures such as dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. Hemostatin Injection functions as an antifibrinolytic agent, inhibiting clot dissolution and thereby controlling bleeding. Administration must be performed by a qualified healthcare provider. Patients with known allergies to this injection should avoid its use. Frequently reported adverse effects encompass injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Prior cardiac surgery or existing renal impairment should be disclosed to your physician. This injection is considered safe for use during pregnancy and lactation, and poses no significant risk to individuals with liver conditions.
Uses of Trenekop Injection
Managing Hemorrhage
Major Benefits of Trenekop Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Trenekop Injection:
- Joint pain
- Headache
- Back pain
- Vomiting
- Nausea
- Abdominal pain
- Diarrhea
- Muscle cramp
- Anemia (low number of red blood cells)
- Lightheadedness
How to use Trenekop Injection:
The medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Trenekop Injection works:
Hemostatic Trenekop Injection inhibits fibrinolysis, thereby stabilizing blood clots and reducing excessive menstrual or post-surgical hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trenekop Injection and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Trenekop Injection use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Trenekop Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Trenekop Injection; the extent is unknown. Avoid driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Trenekop Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Trenekop Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dose modification may be unnecessary for this population. However, physician consultation is advised.
What if you forget to take Trenekop Injection :
Omit a Trenekop Injection dose? Seek your physician's advice.
Facts to Know About Trenekop Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
